Abstract
The effects of protease inhibitors on the intestinal absorption of insulin were investigated in situ in closed small and large intestinal loops in rats, and the stability of insulin was examined in homoge-nates of the small and large intestine. The intestinal absorption of insulin was evaluated by its hypoglycemic effect. When insulin alone was administered into small or large intestinal loops, no marked hypoglycemic response was observed in either region. Of the coadministered protease inhibitors, soybean trypsin inhibitor (1.5, 10 mg/ml) marginally promoted insulin absorption from the large intestine, whereas aprotinin (10 mg/ml) did to a moderate degree. However, a significant hypoglycemic effect was obtained following large intestinal administration of insulin with 20 mM of Na-glycocholate, camostat mesilate and bacitracin, when compared with the controls. In contrast, we found little hypoglycemic effect following small intestinal coadministration of insulin with these protease inhibitors. In the stability experiment, bacitracin, camostat mesilate and Na-glycocholate were effective in reducing insulin degradation in both small and large intestinal homogenates. It was found that the reduction in the proteolytic rate of insulin was related to the decrease in plasma glucose concentration by these protease inhibitors in the large intestine. These findings suggest that coadministration of protease inhibitors would be useful for improving the large intestinal absorption of insulin.
Similar content being viewed by others
REFERENCES
V. H. L. Lee and A. Yamamoto. Penetration and enzymatic barriers to peptide and protein absorption. Adv. Drug Delivery Rev. 4:171–207 (1990).
S. Hirai, T. Yashiki, and H. Mima. Effect of surfactants on the nasal absorption of insulin in rats. Int. J. Pharm. 9:165–172 (1981).
W. A. Ritschel, G. B. Ritschel, H. Forusz, and M. Kraeling. Buccal absorption of insulin in the dog. Res. Commun. Chem. Pathol. Pharmacol. 63:53–67 (1989).
T. Nishihata, J. H. Rytting, A. Kamada, T. Higuchi, M. Routh, and L. Caldwell. Enhancement of rectal absorption of insulin using salicylates in dogs. J. Pharm. Pharmacol. 35:148–151 (1983).
A. Yamamoto, A. M. Luo, S. Dodda-kashi, and V. H. L. Lee. The ocular route for systemic insulin delivery in the albino rabbit. J. Pharmacol. Exp. Ther. 249:249–255 (1989).
H. Okada, I. Yamazaki, Y. Ogawa, S. Hirai, T. Yashiki, and H. Mima. Vaginal absorption of potent luteinizing hormone-releasing hormone analog (leuprolide) in rats I: Absorption by various routes and absorption enhancement. J. Pharm. Sci. 71:1367–1371 (1982).
A. Yamamoto, S. Umemori, and S. Muranishi. Absorption enhancement of intrapulmonary administered insulin by various absorption enhancers and protease inhibitors in rats. J. Pharm. Pharmacol. 46:14–18 (1994).
S. Muranishi. Absorption enhancers. Crit. Rev. Ther. Drug Carrier Syst. 7:1–33 (1990).
M. Hashizume, T. Douen, M. Murakami, A. Yamamoto, K. Takada, and S. Muranishi. Improvement of large intestinal absorption of insulin by chemical modification with palmitic acid in rats. J. Pharm. Pharmacol. 44:555–559 (1991).
K. Yamada, M. Murakami, A. Yamamoto, K. Takada, and S. Muranishi. Improvement of intestinal absorption of thyrotropin-releasing hormone by chemical modification with lauric acid. J. Pharm. Pharmacol. 44:717–721 (1992).
T. Tenma, E. Yodoya, S. Tashima, T. Fujita, M. Murakami, A. Yamamoto, and S. Muranishi. Development of new lipophilic derivatives of tetragastrin: Physicochemical characteristics and intestinal absorption of acyl-tetragastrin derivatives in rats. Pharm. Res. 10:1488–1492 (1993).
M. Saffran, G. S. Kumar, C. Savaiar, J. C. Burnham, F. Williams, and D. C. Neckers. A new approach to the oral administration of insulin and other peptide drugs. Science 233:1081–1084 (1986).
M. Morishita, I. Morishita, K. Takayama, Y. Machida, and T. Nagai. Site-dependent effect of aprotinin, sodium caprate, Na2 EDTA and sodium glycocholate on the intestinal absorption of insulin. Biol. Pharm. Bull. 16:68–72 (1993).
A. Yamamoto, E. Hayakawa, and V. H. L. Lee. Insulin and proinsulin proteolysis in mucosal homogenates of the albino rabbit: Implications in peptide delivery from nonoral routes. Life Sci. 47:2465–2474 (1990).
O. H. Lowry, H. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with folin phenol reagent. J. Biol. Chem. 193:265–275 (1951).
M. Kidron, H. Bar-On, E. M. Berry, and E. Ziv. The absorption of insulin from the various regions of the rat intestine. Life Sci. 31:2837–2841 (1982).
S. J. Hersey, and R. T. Jackson. Effect of bile salts on the nasal permeability in vitro. J. Pharm. Sci. 76:876–879 (1987).
G. S. Gordon, A. C. Moses, R. D. Silver, J. S. Flier, and M. C. Carey. Nasal absorption of insulin: Enhancement by hydrophobic bile salts. Proc. Natl. Acad. Sci. USA 82:7419–7423 (1987).
A. Yamamoto, E. Hayakawa, E. Kato, Y. Nishiura, and V. H. L. Lee. A mechanistic study on enhancement of rectal permeability to insulin in the albino rabbit. J. Pharmacol. Exp. Ther. 263:25–31 (1992).
R. A. Roth. Bacitracin: An inhibitor of the insulin degrading activity of glutathione-insulin transhydrogenase. Biochem. Biophys. Res. Commun. 98:431–438 (1981).
S. C. Raehs, J. Sandow, K. Wirth, and H. P. Merkle. The adjuvant effect of bacitracin on nasal absorption of gonadorelin and buserelin in rats. Pharm. Res. 5:689–693 (1988).
K. Morimoto, H. Yamaguchi, Y. Iwakura, M. Miyazaki, E. Nakatani, T. Iwamoto, Y. Ohashi, and Y. Nakai. Effect of proteolytic enzyme inhibitors on the nasal absorption of vasopressin and an analogue. Pharm. Res. 8:1175–1179 (1991).
M. Saffran, C. Bedra, G. S. Kumar, and D. C. Neckers. Vasopressin: A model for study of effects of additives on the oral and rectal administration of peptides drugs. J. Pharm. Sci. 77:33–38 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yamamoto, A., Taniguchi, T., Rikyuu, K. et al. Effects of Various Protease Inhibitors on the Intestinal Absorption and Degradation of Insulin in Rats. Pharm Res 11, 1496–1500 (1994). https://doi.org/10.1023/A:1018968611962
Issue Date:
DOI: https://doi.org/10.1023/A:1018968611962